Is Cerebral a legitimate company?

Is Cerebral a legitimate company?

Is Cerebral a legitimate company? Yes. Cerebral has licensed therapists in every U.S. state and Washington, D.C. Cerebral is a great fit for people who feel anxious going into an office or have little time to commute to a doctor. Your medical condition could determine whether Cerebral is the right fit for you. The company is best suited for those experiencing depression, anxiety, or insomnia. Therapy Plan. If you only want talk therapy, Cerebral’s Therapy Plan includes weekly sessions with a licensed therapist but does not involve prescriptions. You can get your first month of the Therapy Plan for an introductory rate of $99. After that, it costs $259/month. Cerebral’s Therapy plan starts at $295 per month. This subscription includes weekly sessions with a licensed therapist. If Cerebral is in-network with your insurance plan, your monthly subscription fee starts at just $30 per month under all of our plans.

What kind of company is cerebral?

Cerebral Inc. provides health care software solutions. The Company offers platform which gives access to on-demand mental health and wellness support which includes behavioral health coaching, talk therapy, medication management, and personalized content. Cerebral serves patients in the United States. Cerebral is a subscription-based mental health service provider. A person pays a monthly fee for access to physicians, counselors, and licensed therapists who provide regular online counseling and prescription medication management. Overall, Cerebral is a fairly good online therapy and psychiatry platform for people experiencing a range of mental health conditions. There are several subscriptions to choose from, they accept many major health insurance plans, and you can choose your own provider. Plans on Cerebral range from $99 to $325 per month, depending on the type of care you’re looking for. Medication Plus Care Management costs $99 per month, Therapy costs $259 per month, and Medication Plus Therapy costs $325 per month. What kind of medicine does Cerebral prescribe? Kyle Robertson, Cerebral cofounder and CEO.

Who owns the company Cerebral?

Kyle Robertson, Cerebral cofounder and CEO. Cerebral CEO Dr. David Mou is not focused on a scathing letter sent by Kyle Robertson, his former colleague and the company’s ousted founder, to the mental health startup company’s executive team and investors. Cerebral CEO Dr. David Mou is not focused on a scathing letter sent by Kyle Robertson, his former colleague and the company’s ousted founder, to the mental health startup company’s executive team and investors. Cerebral Inc., a provider of mental-health services, sued founder Kyle Robertson over his alleged refusal to repay more than half of a $49.8 million loan he took out from the SoftBank Group Corp. -backed company. Cerebral Inc., a provider of mental-health services, sued founder Kyle Robertson over his alleged refusal to repay more than half of a $49.8 million loan he took out from the SoftBank Group Corp. -backed company.

Who owns the company cerebral?

Kyle Robertson, Cerebral cofounder and CEO. Cerebral CEO Dr. David Mou is not focused on a scathing letter sent by Kyle Robertson, his former colleague and the company’s ousted founder, to the mental health startup company’s executive team and investors. Cerebral CEO Dr. David Mou is not focused on a scathing letter sent by Kyle Robertson, his former colleague and the company’s ousted founder, to the mental health startup company’s executive team and investors. Robertson is cofounder and CEO of Cerebral, a telemedicine company focused on mental health that offers medication management and therapy through a monthly membership model. Since launching in January 2020, Cerebral has raised $35 million.

What is the Cerebral company scandal?

Cerebral Inc., a provider of mental-health services, sued founder Kyle Robertson over his alleged refusal to repay more than half of a $49.8 million loan he took out from the SoftBank Group Corp. -backed company. Allegations of overprescribing at Cerebral The San Francisco-based company banked $300 million in a series C round in December, boosting its valuation to $4.8 billion. In the lawsuit, Truebe claims Cerebral leadership ignored serious concerns that he raised. Allegations of overprescribing at Cerebral The San Francisco-based company banked $300 million in a series C round in December, boosting its valuation to $4.8 billion. In the lawsuit, Truebe claims Cerebral leadership ignored serious concerns that he raised. Internal documents show Cerebral has a strict protocol for refunds, and customers say the company resists when they seek repayment for services not rendered – until they pull out the big guns. M ental health startup Cerebral’s “Self-Care Sale” advertised 70% off its monthly subscriptions for counseling and medication.